Skip to main content
. 2017 Sep 7;8(46):80315–80324. doi: 10.18632/oncotarget.20699

Figure 4. Vinpocetine inhibited the activation of the TLR4/MyD88 /NF-κB pathway in the microglia OGD model.

Figure 4

A. Effects of the 50 μmol/L vinpocetine treatment on the levels of the TLR4, total and nuclear NF-κB p65 proteins were examined by Western blotting. The vinpocetine treatment inhibited the increase in TLR4 B. Total NF-κB p65 C. and nuclear NF-κB p65 D. expression are shown. E.-G. The vinpocetine treatment inhibited the increase in MyD88 but not TRIF. Data are presented as means±SEM (**p < 0.01).